410 related articles for article (PubMed ID: 35563604)
41. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
Front Immunol; 2018; 9():2727. PubMed ID: 30631320
[TBL] [Abstract][Full Text] [Related]
42. Metabolomic diagnostics and human digital image.
Balashova EE; Lokhov PG; Ponomarenko EA; Markin SS; Lisitsa AV; Archakov AI
Per Med; 2019 Mar; 16(2):133-144. PubMed ID: 30767631
[TBL] [Abstract][Full Text] [Related]
43. Integration of the human exposome with the human genome to advance medicine.
Barouki R; Audouze K; Coumoul X; Demenais F; Gauguier D
Biochimie; 2018 Sep; 152():155-158. PubMed ID: 29960033
[TBL] [Abstract][Full Text] [Related]
44. Metabolomics in the study of retinal health and disease.
Laíns I; Gantner M; Murinello S; Lasky-Su JA; Miller JW; Friedlander M; Husain D
Prog Retin Eye Res; 2019 Mar; 69():57-79. PubMed ID: 30423446
[TBL] [Abstract][Full Text] [Related]
45. Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications-Review.
Shahisavandi M; Wang K; Ghanbari M; Ahmadizar F
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510368
[TBL] [Abstract][Full Text] [Related]
46. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
47. Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies.
Jin Q; Ma RCW
Cells; 2021 Oct; 10(11):. PubMed ID: 34831057
[TBL] [Abstract][Full Text] [Related]
48. Metabolomics toward personalized medicine.
Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
[TBL] [Abstract][Full Text] [Related]
49. Precision Medicine Approach in Prostate Cancer.
Assadi M; Jokar N; Ghasemi M; Nabipour I; Gholamrezanezhad A; Ahmadzadehfar H
Curr Pharm Des; 2020; 26(31):3783-3798. PubMed ID: 32067601
[TBL] [Abstract][Full Text] [Related]
50. Metabolomics in multiple sclerosis disease course and progression.
Bhargava P; Anthony DC
Mult Scler; 2020 Apr; 26(5):591-598. PubMed ID: 31965880
[TBL] [Abstract][Full Text] [Related]
51. Cutting-edge strategies and critical advancements in characterization and quantification of metabolites concerning translational metabolomics.
Pillai MS; Paritala ST; Shah RP; Sharma N; Sengupta P
Drug Metab Rev; 2022 Nov; 54(4):401-426. PubMed ID: 36351878
[TBL] [Abstract][Full Text] [Related]
52. Emerging applications of metabolomics in drug discovery and precision medicine.
Wishart DS
Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
[TBL] [Abstract][Full Text] [Related]
53. Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa.
Shih PB
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():69-76. PubMed ID: 28232135
[TBL] [Abstract][Full Text] [Related]
54. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
Cui L; Lu H; Lee YH
Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
[TBL] [Abstract][Full Text] [Related]
55. A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.
Turi KN; Romick-Rosendale L; Ryckman KK; Hartert TV
J Allergy Clin Immunol; 2018 Apr; 141(4):1191-1201. PubMed ID: 28479327
[TBL] [Abstract][Full Text] [Related]
56. Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.
Goodman SR; Pace BS; Hansen KC; D'alessandro A; Xia Y; Daescu O; Glatt SJ
Exp Biol Med (Maywood); 2016 Apr; 241(7):772-81. PubMed ID: 27022133
[TBL] [Abstract][Full Text] [Related]
57. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
Ahmed Z
Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
[TBL] [Abstract][Full Text] [Related]
58. METABOLOMICS IN MEDICAL SCIENCES--TRENDS, CHALLENGES AND PERSPECTIVES.
Klupczyńska A; Dereziński P; Kokot ZJ
Acta Pol Pharm; 2015; 72(4):629-41. PubMed ID: 26647618
[TBL] [Abstract][Full Text] [Related]
59. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.
Wu X; Wang Z; Luo L; Shu D; Wang K
Front Med Technol; 2022; 4():1065506. PubMed ID: 36688143
[TBL] [Abstract][Full Text] [Related]
60. Translational -omics: Future potential and current challenges in precision medicine.
Wafi A; Mirnezami R
Methods; 2018 Dec; 151():3-11. PubMed ID: 29792918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
